The EU Commission has approved the marketing authorisation variation of Boehringer Ingelheim's PCV2 vaccine Ingelvac CircoFLEX. This approval allows the combined use of the pig vaccines Ingelvac CircoFLEX and Ingelvac MycoFLEX in the European Union.…

Boehringer Ingelheim is offering a free stainless steel bolus applicators, worth £42.60/€ 59.39 (plus VAT), with the first 1,000 Bovikalc multipacks sold after 1^st March in the UK and Eire.

According to the company, milk fever is recognised…

Boehringer Ingelheim Vetmedica Ltd has announced that Metacam is now available for use in pigs as an oral suspension.  

Metacam, which contains the non-steroidal anti-inflammatory drug (NSAID) meloxicam, is indicated for the treatment of non-infectious…

Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.

Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout…

Boehringer Ingelheim has introduced two new pack sizes for its Ingelvac PRRS EU vaccine to help optimise efficiency of treatment and reduce waste.

The new 10ml (10-dose) and 100ml (100-dose) packs of Ingelvac PRRS EU are available now, and will complement…

Boehringer Ingelheim has introduced a new formulation of Metacam, its large animal NSAID. 

Metacam 40 mg/ml solution for injection for cattle and horses contains 40 mg/ml of meloxicam, and is available in either 50 ml or 100 ml presentations. It is approved…

Boehringer Ingelheim has announced the introduction of the Bovela guarantee to underpin its confidence in the live double-deleted (L2D) vaccine. 

The company says Bovela is the only BVD vaccine available proven to provide 12 months’ protection, against…

Boehringer Ingelheim reports that Bovela, the BVD vaccine it launched in March 2015, became the market leader in terms of share of sales per month¹ in July 2017.

Matt Yarnall from Boehringer Ingelheim said: "This is fantastic news for Bovela which offers…

Boehringer Ingelheim Animal Health has announced a change to the datasheet for Mamyzin, its antibiotic treatment for bovine mastitis.

The milk withdrawal has been reduced from 108 hours to 96 hours and the dose is now 15 mg/kg for three consecutive days…

Boehringer Ingelheim Animal Health has launched Mind the Gap, an online tool for veterinary surgeons and farmers to collaboratively develop a bovine viral diarrhoea (BVD) vaccination schedule which avoids immunity gaps.

The idea for an interactive vaccination…

Boehringer Ingelheim Animal Health has announced that its BRD vaccines, Bovalto Respi 3 and Bovalto Respi 4, are now licensed for use in pregnant cows.

Bovalto Respi 3 contains strains of parainfluenza virus 3, bovine respiratory syncytial virus and…

A group of seven European experts in bovine mastitis have issued a statement recommending that all cows on all farms should have an internal teat sealant administered at drying off.

The group, which was convened by Boehringer Ingelheim, made its recommendation…

Boehringer has announced the launch of Ubroseal Dry Cow 2.6 g intramammary suspension for cattle (Bismuth Subnitrate, heavy), the company's first teat sealant.

Ubroseal is licenced for the prevention of new intramammary infections throughout the dry…

Boehringer Ingelheim has launched HatchPak IB H120TM NeO, a freeze-dried live attenuated virus of Bronchitis disease, H120 strain, for active immunisation of one day-old chickens in order to reduce infection with Massachusetts serotype of Infectious Bronchitis…

Boehringer Ingelheim has launched Bovalto Respi Intranasal, an intranasal pneumonia vaccine for calves.

Bovalto Respi Intranasal protects against the two main respiratory viruses – RSV and PI3, using modified live viral strains that have been shown…

Boehringer Ingelheim Animal Health has launched Ubropen (benzylpenicillin procaine monohydrate), an intramammary suspension containing 600mg of Procaine penicillin.

The company says that the composition and dosage of the new product has been optimised…

Boehringer Ingelheim has announced the introduction of a new and improved bottle for its respiratory vaccine, Bovalto Respi Intranasal (IN), which can be used in calves from 10 days of age.

Being an intranasal vaccine, Bovalto Respi IN triggers mucosal…

Boehringer Ingelheim has launched Prevexxion RN and Prevexxion RN+HVT+IBD, the next generation of Marek’s disease vaccines, in the UK and Europe.

Prevexxion RN is composed of a serotype-1 construct vaccine which Boehringer says offers a unique balance…

Boehringer Ingelheim Animal Health has announced that it has ceased production of the flukicide product Trodax 34% w/v Solution for Injection, containing nitroxynil, for the European market.

Trodax is used to treat the mature and late-immature stages of…

Boehringer Ingelheim has announced the launch of TwistPak, billed as a revolutionary mixing platform which allows swine producers to combine and administer two vaccines, Ingelvac CircoFLEX and Ingelvac MycoFLEX, in a convenient, fast and flexible way.

Boehringer Ingelheim Animal Health has announced the launch of Fencovis, a new calf scour vaccine with a prevention claim, which will be available in the UK and Ireland before the end of the year. 

A 2021 German study reported the incidence of diarrhoea to…

Boehringer Ingelheim has launched SoundTalks, an AI device which listens to and analyses the frequency and intensity of pigs coughing, allowing for the earlier detection of respiratory disease. 

Each SoundTalks device has a microphone which covers up to…

DEFRA has granted a permit allowing the use of Bultavo 3, Boehringer Ingelheim's new vaccine against bluetongue virus serotype 3 in sheep and cattle. 

The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting…